[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356619-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356619-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","proteomic-profiling-of-human-extracellular-vesicles-reveals-diagnostic-biomarkers-for-colon-adenocarcinoma","Proteomic Profiling of Human Extracellular Vesicles - Reveals Diagnostic Biomarkers for Colon Adenocarcinoma","","Early detection of colon adenocarcinoma (COAD) remains insufficient. Existing fecal tests miss roughly 30% of stage I cases, and serum CEA shows limited sensitivity. This study profiles extracellular vesicle (EV) proteomes from 233 patients using LC-MS/MS, linking EV cargo to tumor biology and systemic tumor–host interactions. Proteomics identifies COAD-enriched proteins and produces a 10-protein EV panel that separates COAD from healthy controls in two validation cohorts with over 90% sensitivity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proteomic-profiling-of-human-extracellular-vesicles-reveals-diagnostic-biomarkers-for-colon-adenocarcinoma/356619/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proteomic-profiling-of-human-extracellular-vesicles-reveals-diagnostic-biomarkers-for-colon-adenocarcinoma/356619.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are extracellular vesicles promising biomarkers for colon adenocarcinoma?","Question",{"text":63,"@type":64},"EVs circulate systemically and package tumor-related cargo, enabling detection through minimally invasive blood-based signals. The study shows EV protein signatures reflect tumor–host biology in COAD.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the EV proteome and biomarkers studied in this research?",{"text":68,"@type":64},"The researchers profiled EV proteomes from 233 patients using LC-MS/MS. They analyzed stage I–IV tumors, matched non-tumor tissues, pre-/post-operative plasma, and healthy plasma.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the diagnostic performance of the developed EV protein panel?",{"text":72,"@type":64},"A 10-protein EV panel distinguished COAD patients from healthy controls in two validation cohorts (n=104 and n=215), achieving over 90% sensitivity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356619,1790323829,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Journal of Extracellular Vesicles  \nRESEARCH ARTICLE   \nProteomic Profiling of Human Extracellular Vesicles  \nReveals Diagnostic Biomarkers for Colon Adenocarcinoma  \nYura Seo1, 2   Yoon Dae Han3  Linda Bojmar4, 5   Kyung-A Kim1, 2  Yurin Seo1, 2  Taeyul K. Kim1, 2   \nSuho Lee1, 2  Yeleem Kim1, 2  Hye Bin Choi1  Yujin H. Lim1, 2  Chae Hyun Kim1, 2  Alexander Sandberg5  Chuanwen Fan5  Pernille Lauritzen4  Henrik Molina6  Christopher Peralta6  Jacob B. Geri7  Colin Burdette8  Dai Hoon Han3  Heon Yung Gee9  Insuk Lee10  Jeon-Soo Shin11  Hyunwook Kim1  Leon Li4   \nGabriel C. Tobias4  Inbal Wortzel4, 12  Sang Joon Shin1  Hyo-Il Jung13   Min Goo Lee8  Soonmyung Paik14  Robert E. Schwartz15  Joong Bae Ahn1  David Lyden4  Han Sang Kim1, 2, 4   \n1 Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea   \n2 Graduate School of Medical Science, Brain Korea 21 FOUR Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea  3 Division of Colorectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea  4 Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA  5 Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden  6 Proteomics Resource Center, The Rockefeller University, New York, New York, USA  7 Department of Pharmacology, Weill Cornell Medicine, New York, New York, USA  8Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medicine, New York, New York, USA  9 Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea  10 Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea  11 Department of Microbiology, Brain Korea 21 FOUR Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea  12 Department of Cancer Biology and Immunology, Tel-Aviv University, Tel-Aviv, Israel  13 School of Mechanical Engineering, Yonsei University, Seoul, Republic of Korea  14Theragen Bio Co., Ltd, Seongnam-si, South Korea  15 Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA  \nCorrespondence: David Lyden ([dcl2001@med.cornell.edu](dcl2001@med.cornell.edu))  Han Sang Kim (modeerfhs@yuhs.ac)  \nReceived: 4 August 2025  Revised: 19 February 2026  Accepted: 22 March 2026  \nABSTRACT  \nEarly detection of colon adenocarcinoma (COAD) remains suboptimal. Fecal tests fail to diagnose 30% of stage I cancer, and serum CEA lacks sensitivity (\u003C 40%). Extracellular vesicles (EVs) circulate systemically and package tumor-related cargo, making them attractive non-invasive biomarkers for cancer diagnosis. We profiled the EV proteome from 233 human patients using LC-MS/MS, including stage I‑IV tumors with matched non‑tumor colon tissues (n = 50 each; n = 100), paired pre‑/post‑operative plasma (n = 90) and healthy plasma (n = 43) . Circulating EVs contained both tumor-specific and stromal/immune cell-derived proteins, reflecting the systemic nature of EV biology in the cancer setting. Proteomic analysis identified 745 proteins enriched in tumorderived EVs (e.g., SRPK1, THBS2) and 127 proteins enriched in adjacent tissues. Plasma EVs revealed 166 proteins enriched in COAD (e.g., UBA1, FCN1) and 233 enriched in healthy controls. Pathway analysis linked tumor EV cargo to angiogenesis, mRNA splicing, TGF‑β signalling and RNA translation. Notably, a cross-cancer comparison (pancreatic = 10, lung = 14 cases) revealed that 76% of tumor EV proteins were COAD-specific, highlighting tissue of origin specificity. We further developed a 10-protein EV panel comprising seven tumor-associated and thr","cbCaigVTGH9uIg7s","https://ap.wps.com/l/cbCaigVTGH9uIg7s","pdf",5343117,17,"English","# Abstract\n# Introduction\n# One Sentence Summary\n# Key Findings","[{\"question\":\"Why are extracellular vesicles promising biomarkers for colon adenocarcinoma?\",\"answer\":\"EVs circulate systemically and package tumor-related cargo, enabling detection through minimally invasive blood-based signals. The study shows EV protein signatures reflect tumor–host biology in COAD.\"},{\"question\":\"How were the EV proteome and biomarkers studied in this research?\",\"answer\":\"The researchers profiled EV proteomes from 233 patients using LC-MS/MS. They analyzed stage I–IV tumors, matched non-tumor tissues, pre-/post-operative plasma, and healthy plasma.\"},{\"question\":\"What is the diagnostic performance of the developed EV protein panel?\",\"answer\":\"A 10-protein EV panel distinguished COAD patients from healthy controls in two validation cohorts (n=104 and n=215), achieving over 90% sensitivity.\"}]","Proteomic Profiling of Human Extracellular Vesicles - Reveals Diagnostic Biomarkers for Colon Adenocarcinoma | PDF",1790126331,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69c89039f38a40c8305f50b54cce8ac4.webp",983,1283,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6ca8209fc62bd2626d475ae33ec0b44.webp",982,1281,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfaf75383a11b484863b36357748a6a2.webp",981,1280,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef497052b6f60f8421dedde23a0731f6.webp",980,1279]